
Ali M. Imam
Examiner (ID: 14135)
| Most Active Art Unit | 3737 |
| Art Unit(s) | 3737 |
| Total Applications | 818 |
| Issued Applications | 688 |
| Pending Applications | 87 |
| Abandoned Applications | 43 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16748728
[patent_doc_number] => 20210100737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => TRANSDERMAL DELIVERY OF DRONABINOL
[patent_app_type] => utility
[patent_app_number] => 17/062332
[patent_app_country] => US
[patent_app_date] => 2020-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17062332
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/062332 | TRANSDERMAL DELIVERY OF DRONABINOL | Oct 1, 2020 | Abandoned |
Array
(
[id] => 17149451
[patent_doc_number] => 11142513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-12
[patent_title] => Method for simultaneously preparing 2-ethoxyphenol and 1,3-benzodioxolane-2-one
[patent_app_type] => utility
[patent_app_number] => 17/028290
[patent_app_country] => US
[patent_app_date] => 2020-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1664
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17028290
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/028290 | Method for simultaneously preparing 2-ethoxyphenol and 1,3-benzodioxolane-2-one | Sep 21, 2020 | Issued |
| 17/026375 | IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4(PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION | Sep 20, 2020 | Abandoned |
Array
(
[id] => 16710274
[patent_doc_number] => 20210077421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => TREATMENT OF SYNGAP1 ENCEPHALOPATHY
[patent_app_type] => utility
[patent_app_number] => 17/022494
[patent_app_country] => US
[patent_app_date] => 2020-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7497
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17022494
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/022494 | TREATMENT OF SYNGAP1 ENCEPHALOPATHY | Sep 15, 2020 | Abandoned |
Array
(
[id] => 17378111
[patent_doc_number] => 11236108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-01
[patent_title] => Functionalized heterocycles as antiviral agents
[patent_app_type] => utility
[patent_app_number] => 17/022660
[patent_app_country] => US
[patent_app_date] => 2020-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12388
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 283
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17022660
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/022660 | Functionalized heterocycles as antiviral agents | Sep 15, 2020 | Issued |
Array
(
[id] => 20142860
[patent_doc_number] => 12377175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies
[patent_app_type] => utility
[patent_app_number] => 17/016189
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 30141
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016189
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/016189 | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies | Sep 8, 2020 | Issued |
Array
(
[id] => 20142860
[patent_doc_number] => 12377175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies
[patent_app_type] => utility
[patent_app_number] => 17/016189
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 30141
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016189
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/016189 | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies | Sep 8, 2020 | Issued |
Array
(
[id] => 20142860
[patent_doc_number] => 12377175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies
[patent_app_type] => utility
[patent_app_number] => 17/016189
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 30141
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016189
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/016189 | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies | Sep 8, 2020 | Issued |
Array
(
[id] => 20142860
[patent_doc_number] => 12377175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies
[patent_app_type] => utility
[patent_app_number] => 17/016189
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 30141
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016189
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/016189 | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies | Sep 8, 2020 | Issued |
Array
(
[id] => 16525126
[patent_doc_number] => 20200399206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => METHODS AND COMPOSITIONS FOR TERPENOID TRICYCLOALKANE SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 17/013902
[patent_app_country] => US
[patent_app_date] => 2020-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26372
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17013902
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/013902 | Methods and compositions for terpenoid tricycloalkane synthesis | Sep 7, 2020 | Issued |
Array
(
[id] => 17851870
[patent_doc_number] => 20220281912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => COMPOUNDS FOR USE IN THE TREATMENT OF LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/630291
[patent_app_country] => US
[patent_app_date] => 2020-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17630291
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/630291 | Compounds for use in the treatment of liver disease | Aug 13, 2020 | Issued |
Array
(
[id] => 16466642
[patent_doc_number] => 20200368179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
[patent_app_type] => utility
[patent_app_number] => 16/989605
[patent_app_country] => US
[patent_app_date] => 2020-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16989605
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/989605 | USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY | Aug 9, 2020 | Abandoned |
Array
(
[id] => 17163006
[patent_doc_number] => 11149093
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-19
[patent_title] => Antibodies to symmetrically dimethylated arginine analytes and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/988418
[patent_app_country] => US
[patent_app_date] => 2020-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 20
[patent_no_of_words] => 23970
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16988418
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/988418 | Antibodies to symmetrically dimethylated arginine analytes and use thereof | Aug 6, 2020 | Issued |
Array
(
[id] => 16468292
[patent_doc_number] => 20200369829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => METHOD FOR PREPARING POLYOLS
[patent_app_type] => utility
[patent_app_number] => 16/987153
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16747
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16987153
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/987153 | METHOD FOR PREPARING POLYOLS | Aug 5, 2020 | Abandoned |
Array
(
[id] => 16452463
[patent_doc_number] => 20200361889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => FUNCTIONALIZED BIO-BASED CROSSLINKERS
[patent_app_type] => utility
[patent_app_number] => 16/986283
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7490
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16986283
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/986283 | Functionalized bio-based crosslinkers | Aug 5, 2020 | Issued |
Array
(
[id] => 16908928
[patent_doc_number] => 11040953
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-22
[patent_title] => Process for the preparation of a diarylthiohydantoin compound
[patent_app_type] => utility
[patent_app_number] => 16/939976
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5060
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16939976
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/939976 | Process for the preparation of a diarylthiohydantoin compound | Jul 26, 2020 | Issued |
Array
(
[id] => 19196546
[patent_doc_number] => 11993775
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Ubiquitin-specific peptidase 24 inhibitor, medicinal composition and method of delaying or reversing multidrug resistance in cancers using the same
[patent_app_type] => utility
[patent_app_number] => 16/939543
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 68
[patent_no_of_words] => 6371
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16939543
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/939543 | Ubiquitin-specific peptidase 24 inhibitor, medicinal composition and method of delaying or reversing multidrug resistance in cancers using the same | Jul 26, 2020 | Issued |
Array
(
[id] => 16435569
[patent_doc_number] => 20200352894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => COMBINATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/937916
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42967
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16937916
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/937916 | COMBINATION THERAPY | Jul 23, 2020 | Abandoned |
Array
(
[id] => 16570495
[patent_doc_number] => 20210009501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/936256
[patent_app_country] => US
[patent_app_date] => 2020-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16936256
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/936256 | Treprostinil derivatives and compositions and uses thereof | Jul 21, 2020 | Issued |
Array
(
[id] => 17837650
[patent_doc_number] => 20220274955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS
[patent_app_type] => utility
[patent_app_number] => 16/932072
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16932072
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/932072 | Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders | Jul 16, 2020 | Issued |